Alprazolam .25mg cost
The dosage should be reduced slowly to minimise withdrawal symptoms. Some patients may require an even slower dosage reduction. Side effects, are generally observed at the beginning of therapy and usually disappear upon continued medication or decreased dosage.
In patients treated for anxiety, anxiety associated with depression, the most common side-effects to Alzam alprazolam were drowsiness, sedation and ataxia. Drowsiness is more common in elderly and debilitated patients and in patients receiving high doses. Less common side-effects are: The following side-effects have also been reported: Stimulation, agitation, irritability, concentration difficulties, confusion, hallucinations, other adverse behavioural effects, musculoskeletal weakness, dystonia, fatigue, slurred speech, anorexia, changes in salivation, changes in libido, menstrual irregularities, incontinence, urinary retention, abnormal liver function, jaundice, blood disorders, increased intra-ocular pressure and hypersensitivity reactions.
Amnesia and paradoxical excitation may occur. In the case of acute, hyperexcitability states, the medicine should be discontinued.
The usual precautions for treating patients with impaired renal or hepatic function, pulmonary disease and limited pulmonary reserve should be observed. Paradoxical reactions such as excitement and irritability may occur in children.
Smaller children are more prone to these reactions. Alzam is not recommended for the primary treatment of psychotic illness. Alzam should of be used alone to treat depression or anxiety with depression; suicide may be precipitated in such patients. Alzam should be used with extreme caution in patients with a history of alcohol or drug abuse. There have been occasional voluntary reports of patients developing seizures while apparently tapering gradually from XANAX.
Status Epilepticus and its Treatment The medical event voluntary reporting system shows that withdrawal seizures have been reported in association with the discontinuation of XANAX.
In most cases, only a single seizure was reported; however, multiple seizures and status epilepticus were reported as well. These symptoms may reflect the development of tolerance or a time interval between doses which is longer than the duration of clinical action of the administered dose. In either case, it is presumed that the prescribed dose is not sufficient to maintain plasma levels above those needed to prevent relapse, rebound or withdrawal symptoms over the entire course of the interdosing interval.
Risk of Dose Reduction Withdrawal reactions may occur when dosage reduction occurs for any reason. This includes purposeful tapering, but also inadvertent reduction of dose eg, the patient forgets, the patient is admitted to a hospital. CNS Depression and Impaired Performance Because of its CNS depressant effects, patients receiving XANAX should be cautioned against engaging in hazardous occupations or activities requiring complete mental alertness such as operating machinery or driving a motor vehicle.
For the same reason, patients should be cautioned about the simultaneous ingestion of alcohol and other CNS depressant drugs during treatment with XANAX. Risk of Fetal Harm Benzodiazepines can potentially cause fetal harm when administered to pregnant women.
If XANAX is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.
Because of experience with other members of the benzodiazepine class, XANAX is assumed to be capable of causing an increased risk of congenital abnormalities when administered to a pregnant woman during the first trimester.
Because use of these drugs is rarely a matter of urgency, their use during the first trimester should almost always be avoided. The possibility that a woman of childbearing potential may be pregnant at the time of institution of therapy should be considered.
Patients should be advised that if they become pregnant during therapy or intend to become pregnant they should communicate with their physicians about the desirability of discontinuing the drug.
Drugs that inhibit this metabolic pathway may have a profound effect on the clearance of alprazolam. Consequently, alprazolam should be avoided in patients receiving very potent inhibitors of CYP3A. With drugs inhibiting CYP3A to a lesser but still significant degree, alprazolam should be used only with caution and consideration of appropriate dosage reduction.
The coadministration of alprazolam with these agents is not recommended. Drugs demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving alprazolam caution and consideration of appropriate alprazolam dose reduction are recommended during coadministration with the following drugs Nefazodone Coadministration of nefazodone increased alprazolam concentration two-fold. HIV protease inhibitors Interactions involving HIV protease inhibitors eg, ritonavir and alprazolam are complex and time dependent.
Low doses of ritonavir resulted in a large impairment of alprazolam clearance, prolonged its elimination half-life and enhanced clinical effects. However, upon extended exposure to ritonavir, CYP3A induction offset this inhibition.
This interaction will require a dose-adjustment or discontinuation of alprazolam. Panic disorder has been associated with primary and secondary major depressive disorders and increased reports of suicide among untreated patients.
Mania Episodes of hypomania and mania have been reported in association with the use of XANAX in patients with depression. Uricosuric Effect Alprazolam has a weak uricosuric effect. Although other medications with weak uricosuric effect have been reported to cause acute renal failure, there have been no reported instances of acute renal failure attributable to therapy with XANAX. Use in Patients with Concomitant Illness It is recommended that the dosage be limited to the smallest effective dose to preclude the development of ataxia or oversedation which may be a particular problem in elderly or debilitated patients.
The usual precautions in treating patients with impaired renal, hepatic or pulmonary function should be observed. There have been rare reports of death in patients with severe pulmonary disease shortly after the initiation of treatment with XANAX.
Advise both patients and caregivers about the risks of potentially fatal respiratory depression and sedation when XANAX is used with opioids and not to use such drugs concomitantly unless supervised by a health care provider. Inform your physician about any alcohol consumption and medicine you are taking now, including medication you may buy without a prescription.
Alcohol should generally not be used during treatment with benzodiazepines. Not recommended for use in pregnancy. Therefore, inform your physician if you are pregnant, if you are planning to have a child, or if you become pregnant while you are taking this medication.
Inform your physician if you are nursing. Until you experience how this medication affects you, do not drive a car or operate potentially dangerous machinery, etc. Do not increase the dose even if you think the medication "does not work anymore" without consulting your physician.
Do not stop taking this medication abruptly or decrease the dose without consulting your physician, since withdrawal symptoms can occur.
In all cases, it is important that your physician help you discontinue this medication in a careful and safe manner to avoid overly extended use of XANAX.
These are generally minor but seizure can occur, especially if you reduce the dose too rapidly or discontinue the medication abruptly. Seizure can be life-threatening. Laboratory Tests Laboratory tests are not ordinarily required in otherwise healthy patients.
However, when treatment is protracted, periodic blood counts, urinalysis, and blood chemistry analyses are advisable in keeping with good medical practice. Drug Interactions Use with Opioids The concomitant use of benzodiazepines and opioids increases the risk of respiratory depression because of actions at different receptor sites in the CNS that control respiration.
When benzodiazepines and opioids are combined, the potential for benzodiazepines to significantly worsen opioid-related respiratory depression exists. The starting dose for treating panic disorder is 0. This dosage may be increased every three to four days until the total daily dosage ranges from 2—10 mg.
The total amount should be divided in at least three even daily doses. Average doses for anxiety associated with depression range from 2. Precautions Alprazolam should not be used by patients who are pregnant, have narrow angle glaucoma, take ketoconazole or itraconazole, or those who are allergic to this or any other benzodiazepine drug.
The dose of alprazolam must be carefully regulated and individualized in the elderly over age 60 , people with liver or kidney disease, and those taking other medications used to treat mental disorders. Because alprazolam is a nervous system and respiratory depressant, it should not be taken with other similar depressants, such as alcohol, other sedatives, sleeping pills, or tranquilizers. People taking this drug should not drive, operate dangerous machinery, or engage in hazardous activities that require mental alertness at least until they see how the drug affects them.
Alprazolam should be used under close physician supervision in patients with history of substance abuse. Like other benzodiazepines, alprazolam can be habit-forming. Risk and severity of dependence appears greater in patients taking doses larger than 4 mg daily.
However, smaller doses may cause dependence if alprazolam is taken longer than 12 weeks. Suddenly discontinuing alprazolam after several weeks may cause uncomfortable symptoms of withdrawal. Withdrawal symptoms in people who have taken alprazolam three months or longer may include seizures , anxiety, nervousness, and headache. Patients should discuss with their doctor how to gradually discontinue alprazolam use to avoid such symptoms.
DESCRIPTION
Generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry apprehensive expectation about two or more life metronidazole price cvs, for a period of 6 months or longer, during which the person has been bothered more days than not by these concerns, alprazolam .25mg cost. In patients with alcoholic liver disease the half-life of alprazolam ranged between 5. Advise both patients and caregivers about the risks of potentially fatal respiratory depression and sedation when XANAX is used with opioids and not to use such drugs concomitantly unless supervised by a health care provider. Risk of Fetal Harm Benzodiazepines can potentially cause fetal harm when administered to pregnant women. Motor Tension trembling, twitching, or feeling shaky; muscle tension, aches, or soreness; restlessness; easy fatigability ; Autonomic Hyperactivity shortness of breath or smothering sensations; palpitations or accelerated heart rate; sweating, or cold clammy hands; dry mouth; dizziness or light-headedness; nausea, diarrhea, or other abdominal distress; flushes or chills; frequent urination; trouble swallowing or 'lump in throat' ; Vigilance and Scanning feeling keyed up or on edge; exaggerated startle response; difficulty concentrating or 'mind cost blank' because of anxiety; trouble falling or staying asleep; irritability. Like other benzodiazepines, alprazolam can be habit-forming. To do this, they block the effects of a specific chemical involved in the transmission of nerve impulses in the braindecreasing the excitement level of the nerve cells. For the alprazolam reason, patients should be cautioned about the simultaneous ingestion of alcohol and other CNS depressant drugs during treatment with XANAX. For example, an anxiolytic drug may relieve dry mouth [a symptom of anxiety] in some subjects but induce it [an untoward event] in others. Laboratory Tests Laboratory tests are not ordinarily required in otherwise healthy patients. The possibility that a woman of childbearing potential may be pregnant at the time of institution of therapy should be considered. Also read cost about Alprazolam from Wikipedia Alprazolam Contributions: However, in a controlled postmarketing discontinuation study of panic disorder patients, the duration of treatment 3 months compared to 6 months had no effect on the ability of patients to taper to zero dose. .25mg reported relative potencies in benzodiazepine receptor binding experiments and in animal models of induced seizure inhibition are 0. Inform your physician if you .25mg nursing. These signs, and symptoms, especially the more serious ones are generally more common in those patients who have received excessive doses over an extended period of time, alprazolam .25mg cost. Panic disorder has been associated cost primary and secondary major depressive disorders alprazolam increased reports of .25mg among untreated patients.